Development of a binational thyroid cancer clinical quality registry: a protocol paper

Author:

Ioannou Liane J,Serpell Jonathan,Dean Joanne,Bendinelli Cino,Gough Jenny,Lisewski Dean,Miller Julie A,Meyer-Rochow Win,Sidhu Stan,Topliss Duncan,Walters David,Zalcberg John,Ahern Susannah

Abstract

IntroductionThe occurrence of thyroid cancer is increasing throughout the developed world and since the 1990s has become the fastest increasing malignancy. In 2014, a total of 2693 Australians and 302 New Zealanders were diagnosed with thyroid cancer, with this number projected to rise to 3650 in 2018. The purpose of this protocol is to establish a binational population-based clinical quality registry with the aim of monitoring and improving the quality of care provided to patients diagnosed with thyroid cancer in Australia and New Zealand.Methods and analysisThe Australian and New Zealand Thyroid Cancer Registry (ANZTCR) aims to capture clinical data for all patients over the age of 16 years with thyroid cancer, confirmed by histopathology report, who have been diagnosed, assessed or treated at a contributing hospital. A multidisciplinary steering committee was formed which, with operational support from Monash University, established the ANZTCR in early 2017. The pilot phase of the registry is currently operating in Victoria, New South Wales, Queensland, Western Australia and South Australia, with over 20 sites expected to come on board across Australia in 2018. A modified Delphi process was undertaken to determine the clinical quality indicators to be reported by the registry, and a minimum data set was developed comprising information regarding thyroid cancer diagnosis, pathology, surgery and 90-day follow-up.Future plansThe establishment of the ANZTCR provides the opportunity for Australia and New Zealand to further understand current practice in the treatment of thyroid cancer and identify variation in outcomes. The engagement of endocrine surgeons in supporting this initiative is crucial. While the pilot registry has a focus on early clinical outcomes, it is anticipated that future collection of longer term outcome data particularly for patients with poor prognostic disease will add significant further value to the registry.

Funder

Australian and New Zealand Endocrine Surgeons

Publisher

BMJ

Subject

General Medicine

Reference40 articles.

1. Western Australian Cancer Registry. Cancer incidence and mortality in Western Australia. Data Integrity directorate PaSPD. editor. Perth Western Australia: Department of Health, 2014.

2. Australian Government. Cancer in Australia: an overview. 2012Australian Institute of Health and Welfare (AIHW), Australasian Association of Cancer Registries. editors. Canberra: AIHW, 2012.

3. Australian Government. Australian Cancer Database (ACD). Australian Institute of Health and Welfare (AIHW), Australasian Association of Cancer Registries. editors. Canberra: AIHW, 2011.

4. Cancer Data and Stats. Mo H , ed. New Zealand Cancer Registry (NZCR). Wellington: New Zealand Government, 2017.

5. Australian Government. National Mortality Database (NMD). Australian Institute of Health and Welfare (AIHW), Australasian Association of Cancer Registries. editors. Canberra: AIHW, 2011.

Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3